Last updated on October 2016

French Registry of First-line Treatment of Acute Promyelocytic Leukemia


Brief description of study

The registry aims to compare the two first-line available treatment approaches in non-high-risk APL patients aged ≤ 70 years - ATRA plus chemotherapy and ATRA plus ATO - in terms of practitioner's choice between the two options, clinical effectiveness and cost-effectiveness, long-term outcome, and short- and long-term toxic effects.

Detailed Study Description

- Collection of epidemiological data on non-high-risk APL patients aged ≤ 70 years: age and sex distribution, medical history, prognostic factors (time to treatment start, severity of coagulopathy at presentation, Performance status…). - Documentation of clinical and biologic effectiveness of the two first-line treatment approaches available for non-high-risk APL patients. - Documentation of Minimal Residual Disease (MRD). - Correlation of clinical outcomes with the chosen therapy. - Validation of published prognostic factors and identification of new prognostic factors

Clinical Study Identifier: NCT02938858

.

Contact Investigators or Research Sites near you

Start Over

Please choose location

View all locations

Sylvie CAILLERES, MD

Centre Hospitalier d'Aix en Provence
Aix en Provence, France
  Connect »

Delphine LEBON, MD

Groupe Hospitalier SUD
Amiens, France
  Connect »

Ahmad ALJIJAKLI, MD

Centre Hospitalier V. Dupouy
Argenteuil, France
  Connect »

Fabrice LAROSA, MD

H pital Jean Minjoz
Besançon, France
  Connect »

Charlotte JUBERT, MD

CHU Bordeaux Pellegrin enfant
Bordeaux, France
  Connect »

Liana CARAUSU, MD

CHRU de Brest - P diatrie Sp cialis e
Brest, France
  Connect »

Victoria CACHEUX, MD

CHU Estaing
Clermont-Ferrand, France
  Connect »

Florence BECKERICH, MD

H pital Henri Mondor
Créteil, France
  Connect »

Martin CARRE, MD

CHU de Grenoble
Grenoble, France
  Connect »

Anne-Laure TAKSIN, MD

Hopital Andre Mignot
Le Chesnay, France
  Connect »

Brigitte DUPRIEZ, MD

CH Dr Schaffner
Lens, France
  Connect »

Céline BERTHON, MD

Chru - Hopital Claude Huriez
Lille, France
  Connect »

Marie-Pierre GOURIN, MD

H pital universitaire Dupuytren
Limoges, France
  Connect »

Norbert VEY, MD

Institut Paoli Calmettes
Marseille, France
  Connect »

Gérard MICHEL, MD

Chu Timone
Marseille, France
  Connect »

Houria DEBARRI, MD

CHR Metz-Thionville - H pital de Marcy
Metz, France
  Connect »

Yosr HICHERI, MD

CHU Saint Eloi
Montpellier, France
  Connect »

Pierre PETERLIN, MD

CHU H tel Dieu
Nantes, France
  Connect »

Diana CARP, MD

H pital de la Source
Orléans, France
  Connect »

Jean DONADIEU, MD

H pital TROUSSEAU
Paris, France
  Connect »

Ambroise MARCAIS, MD

H pital Necker
Paris, France
  Connect »

Benoit BRETHON, MD

H pital Robert Debr
Paris, France
  Connect »

Virginie GANDEMER, MD

CHU H pital Sud - service H mato-oncologie P diatrique
Rennes, France
  Connect »

Isabelle DERVITE, MD

H pital V. Provo
Roubaix, France
  Connect »

Aspasia STAMATOULLAS, MD

Centre Henri Becquerel
Rouen, France
  Connect »

Emmanuelle TAVERNIER, MD

Institut de Cancerologie de La Loire
Saint Priest-en-jarez, France
  Connect »

Christian RECHER, MD

IUCT Oncopole
Toulouse, France
  Connect »